Medtronic Plc (NYSE: MDT) has a higher price-to-earnings ratio of 24.10x compared to its average ratio. MDT has 36-month beta value of 0.82. Analysts have mixed views on the stock, with 13 analysts rating it as a “buy,” 5 as “overweight,” 13 as “hold,” and 1 as “sell.”
The public float for MDT is 1.28B, and currently, short sellers hold a 0.66% ratio of that float. The average trading volume of MDT on July 01, 2025 was 7.93M shares.
MDT) stock’s latest price update
Medtronic Plc (NYSE: MDT) has experienced a rise in its stock price by 1.34 compared to its previous closing price of 86.02. However, the company has seen a gain of 1.41% in its stock price over the last five trading days. zacks.com reported 2025-06-30 that Medtronic (MDT) closed the most recent trading day at $87.17, moving +1.34% from the previous trading session.
MDT’s Market Performance
MDT’s stock has risen by 1.41% in the past week, with a monthly rise of 5.78% and a quarterly drop of -0.52%. The volatility ratio for the week is 1.44% while the volatility levels for the last 30 days are 1.54% for Medtronic Plc The simple moving average for the past 20 days is 0.65% for MDT’s stock, with a 0.07% simple moving average for the past 200 days.
Analysts’ Opinion of MDT
Leerink Partners, on the other hand, stated in their research note that they expect to see MDT reach a price target of $110. The rating they have provided for MDT stocks is “Outperform” according to the report published on June 16th, 2025.
Citigroup gave a rating of “Buy” to MDT, setting the target price at $107 in the report published on March 04th of the current year.
MDT Trading at 2.68% from the 50-Day Moving Average
After a stumble in the market that brought MDT to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -9.43% of loss for the given period.
Insider Trading
Wall Brett A., the EVP & Pres Neuroscience of Medtronic Plc, sale 12,437 shares at $90.00 during a trade that took place back on Jan 24 ’25, which means that Wall Brett A. is holding 40,979 shares at $1,119,330 based on the most recent closing price.
Stock Fundamentals for MDT
Current profitability levels for the company are sitting at:
- 0.18 for the present operating margin
- 0.64 for the gross margin
The net margin for Medtronic Plc stands at 0.14. The total capital return value is set at 0.08. Equity return is now at value 9.49, with 5.13 for asset returns.
Based on Medtronic Plc (MDT), the company’s capital structure generated 0.37 points at debt to capital in total, while cash flow to debt ratio is standing at 0.25. The debt to equity ratio resting at 0.59. The interest coverage ratio of the stock is 8.17.
Currently, EBITDA for the company is 5.96 billion with net debt to EBITDA at 3.16. When we switch over and look at the enterprise to sales, we see a ratio of 4.11. The receivables turnover for the company is 5.15for trailing twelve months and the total asset turnover is 0.37. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.85.
Conclusion
To put it simply, Medtronic Plc (MDT) has had a better performance in recent times. Analysts have a mixed opinion on the stock, with some rating it as a “buy” and others as a “hold”. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
